Spero Therapeutics SPRO
NASDAQ SPRO
$1.17 -0.05 (-4.10%)
At close: Oct 21, 2026 · 4:00 PM EDT

Spero Therapeutics (SPRO) Other Operating Expenses (2023 - 2025)

Updated

Spero Therapeutics (SPRO) recorded Other Operating Expenses of $587,000 in FY2025.

Analysis

Spero Therapeutics (SPRO) Other Operating Expenses (2023 - 2025) Analysis & Trends

  • Per Business Quant data, SPRO's Other Operating Expenses was $5.31 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Spero Therapeutics 68.40 Mn -127.38 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 587,000.00
Sep 30, 2023 5.31 Mn
API Access

Spero Therapeutics Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=SPRO&period=max&api_key=YOUR_API_KEY